Background. Gaucher disease is an autosomal recessive lysosomal storage disorder caused by deficiency of the enzyme glucocerebrosidase, which is required for the degradation of glycosphingolipids. Skeletal involvement is one of the main manifestations of the disease and is present in 70–100 % of patients. However, the rarity of Gaucher disease and non-specific and heterogeneous nature of its symptoms and radiological signs may impede consideration of this disease in the differential diagnosis.Aim. To describe the radiological signs of bone involvement in type I Gaucher disease and assess the role of MRI in the evaluation of the severity of the disease in newly diagnosed patients.Materials and methods. X-ray and MRI data of 86 treatment-naïve Gaucher patients were included in the retrospective analysis. Bone marrow involvement, as well as bone and joint pathological changes, were evaluated.Results. Radiological signs of bone involvement in Gaucher patients were described and classified into 2 groups, i.e. reversible and irreversible. Such a classification is important in terms of the assessment of the overall disease severity. MRI has proven to be a sensitive method for detection and evaluation of the reversible bone changes in Gaucher patients.Conclusion. Although radiological manifestations of bone involvement in Gaucher patients are typical, they may significantly vary and be present in various combinations. MRI is the gold standard for the assessment of bone marrow changes in patients with Gaucher disease.
14 March 2019 in Journal of radiology and nuclear medicine
BACKGROUND: Osteonecrosis of the femoral head in Gaucher disease type I is an irreversible bone manifestation of the disease. The cause and mechanisms of osteonecrosis in Gaucher disease are still unknown, and their clinical and radiological characteristics must be taken into account when choosing treatment strategy. AIM: To analyze the radial and morphological changes in the proximal femur after osteonecrosis of the femoral head in type I Gaucher disease. MATERIALS AND METHODS: The study included 251 adult patients with type I Gaucher disease from the Russian National Registry; histological examination of 22 removed femoral bone fragments obtained during total hip replacement in 20 patients with Gaucher disease and 9 in patients of the control group was performed. RESULTS: Aseptic necrosis of the femoral head was found in 30% adults with Gaucher disease, and in 20% patients it was associated with femoral head collapse. Osteosclerosis of the cancellous bone of the metaphysis, enlargement / swelling of the medullary cavity with secondary osteopenia and osteoporosis of the proximal femoral diaphysis often accompanied osteonecrosis of the femoral head, causing technical difficulties during surgery. The histological findings revealed a picture of chronic bone tissue ischaemia of the proximal femoral metaphysis, which was confirmed by the detection of widespread areas of osteosclerosis on radiography and MRI. Bone marrow infiltration by Gaucher cells in histological preparations persisted regardless of the duration of enzyme replacement therapy against the background of preserved regenerative potential of bone tissue. CONCLUSIONS: The features of the radiological, MRI and histological picture should be taken into account when planning and performing orthopaedic surgery for aseptic necrosis of the femoral head in patients with type I Gaucher disease.
BACKGROUND. Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal hematologic disease manifesting among others in hemolytic anemia. Due to predominantly intravascular hemolysis, iron metabolism in PNH patients is characterized by a number of features. Pathogenetic treatment with complement C5-inhibitors modifies the course of hemolysis and results in iron metabolic changes. AIM. To characterize the serum parameters of iron metabolism in PNH patients and to evaluate T2* MRIs of the liver and kidneys. MATERIALS & METHODS. Serum parameters of iron metabolism measured in 97 analyses and 99 T2* MRIs of the liver and kidneys were assessed in 82 PNH patients treated at the National Research Center for Hematology from 2018 to 2024. Patients were 21–76 years of age (median 39 years); there were 38 women and 44 men. RESULTS. The analysis focused on the data from 78 PNH patients. Among non-recipients of C5-inhibitors, iron overload in liver tissue was identified in 10/38 (26.3 %) patients. In C5-inhibitor recipients, iron overload in liver tissue was found significantly more often, i.e. in 28/40 (70 %) patients. Iron overload in liver tissue was more pronounced in patients with suboptimal hematologic response to PNH therapy. A renal T2* MRI was performed in 71 patients. In all non-recipients of C5-inhibitors (n = 34), iron overload in renal tissue was detected. In C5-inhibitor recipients, iron overload in renal tissue occurred significantly less often, i.e. in 21/37 (57 %) patients. CONCLUSION. Iron overload in renal cortex was identified in all PNH patients who were not treated with C5-inhibitors. Iron overload in liver tissue was associated with blood transfusions and suboptimal hematologic response to pathogenetic PNH therapy. In evaluating iron overload in liver and renal tissues, laboratory methods for assessing iron metabolism in PNH patients have lower sensitivity compared to T2* MRI. In PNH patients, the achievement of optimal response to C5-inhibitor treatment is associated with a decrease in severity of iron overload in renal tissue and no hepatic hemosiderosis.
Differential diagnosis of bone involvement in patients with Gaucher disease can be challenging. Other diseases with similar radiological signs should be ruled out. Here we present a clinical case of tuberculous sacroiliitis in the patient with type I Gaucher disease. Advanced radiological methods of examination are described. Our case report proves the necessity of an individual approach to the management of such cohort of patients. Keywords: Gaucher disease, tuberculosis of bones and joints, differential diagnosis, comprehensive treatment. Keywords: Gaucher disease, tuberculosis of bones and joints, differential diagnosis, comprehensive treatment
Mezenkhimal'nye stvolovye kletki v lechenii eksperimental'nogo ishemicheskogo insul'ta: terapevticheskie effekty, migratsiya kletok i oslozhneniya posle vnutriarterial'nogo vvedeniya u krys Мезенхимальные стволовые клетки в лечении экспериментального ишемического инсульта: терапевтические эффекты, миграция клеток и осложнения после внутриартериального введения у крыс